BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $10.0B | +0.3% |
| Gross profit | $7.4B | −1.6% |
| Operating income | $2.5B | −33.1% |
| Net income | $835M | −45.5% |
| EPS | $5.65 | −46.0% |
| Free cash flow | $2.7B | +36.3% |
Biogen Inc.
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $10.0B | +0.3% |
| Gross profit | $7.4B | −1.6% |
| Operating income | $2.5B | −33.1% |
| Net income | $835M | −45.5% |
| EPS | $5.65 | −46.0% |
| Free cash flow | $2.7B | +36.3% |